Question to the Department of Health and Social Care:

To ask Her Majesty’s Government what progress has been made in any negotiations with the manufacturers of Meningitis B vaccine Bexsero; and when those negotiations are due to conclude.

We have had a number of meetings with the manufacturer for supply of the meningococcal B vaccine, Bexsero^® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation, and we are continuing to meet.

The Department is conducting these negotiations on behalf of the devolved administrations, as is usual and agreed practice.